| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/03/2007 | EP1476467B9 Immunoglobulin igg3 as a marker for protecting against infectious viral diseases, and the uses of the same |
| 01/03/2007 | EP1401872B1 Antigen targeting |
| 01/03/2007 | EP1390403B1 Peptides derived from neural thread proteins and their medical use |
| 01/03/2007 | EP1385876B1 Gonococcal proteins and nucleic acids |
| 01/03/2007 | EP1278534B1 Methods and compositions for impairing multiplication of hiv-1 |
| 01/03/2007 | EP1173765B1 Diagnostic and therapeutic use of antibodies against the urokinase receptor |
| 01/03/2007 | EP1108435B1 Preventives or remedies for pancreatitis containing anti-il-6 receptor antibodies as the active ingredient |
| 01/03/2007 | EP1107773B1 Method for detection of legionella bacteria employing purified antigen-specific antibodies |
| 01/03/2007 | EP1104462B1 Bpc-1: a secreted brain specific protein expressed and secreted by prostate and bladder cancer cells |
| 01/03/2007 | EP1025220B1 JMY, A CO-ACTIVATOR FOR p300/CBP, NUCLEIC ACID ENCODING JMY AND USES THEREOF |
| 01/03/2007 | EP0896626B1 Monoclonal antibody to cea, conjugates comprising said antibody, and their therapeutic use in an adept system |
| 01/03/2007 | EP0771213B1 Haemophilus influenzae adherence and penetration proteins |
| 01/03/2007 | EP0726952B1 Receptor on the surface of activated t-cells:acts-4 |
| 01/03/2007 | EP0669929B1 Elk ligand, a cytokine |
| 01/03/2007 | EP0526452B2 Hybrid immunoglobulins |
| 01/03/2007 | CN1890567A Angiogenesis inhibiting molecules and their use in the treatment and diagnosis of cancer |
| 01/03/2007 | CN1890369A Bispecific antibody substituting for functional proteins |
| 01/03/2007 | CN1890266A Antibodies |
| 01/03/2007 | CN1889979A IP-10 antibodies and their uses |
| 01/03/2007 | CN1889978A Interferon alpha antibodies and their uses |
| 01/03/2007 | CN1888057A Hybrid tumor cell strain and its produced human alpha-galactosidase A resisting monoclonal antibody |
| 01/03/2007 | CN1888056A Immuno colloidal gold test paper strip for detecting sulfa drug residue |
| 01/03/2007 | CN1887908A Synthesis process of olaquindox artificial antigen |
| 01/03/2007 | CN1887901A Human tumor M2-type pyruvate kinase antigen determinant polypeptide and antibody and their application in diagnositic kit |
| 01/03/2007 | CN1887829A Synthesis process of 18F lebeled positive electron radioactive tracer with ionic liquid as phase transfer catalyst |
| 01/03/2007 | CN1293190C Cell surface molecule mediating cell adhesion and signal transmission |
| 01/03/2007 | CN1293098C Concatameric immunoadhesion |
| 01/03/2007 | CN1293097C Glycyrrhizic acid anti-body and its preparing method and use |
| 01/03/2007 | CN1292655C Stable liquid pharmaceutical formulation of IgG antibodies |
| 01/02/2007 | US7157569 Comprises nucleotide sequences coding gamma aminobutyric acid type A (GABAA) receptor for diagnosis and treatment of brain, anxiety, depressive, nervous system, migraine and/or obesity disorders |
| 01/02/2007 | US7157565 Far red shifted fluorescent proteins |
| 01/02/2007 | US7157562 Bioprocess for the production of recombinant anti-botulinum toxin antibody |
| 01/02/2007 | US7157561 Methods of inhibiting transmission of a costimulatory signal of lymphocytes |
| 01/02/2007 | US7157560 Antibody for use as diagnostic tool in immunoassays |
| 01/02/2007 | US7157556 Deglycosylated kringle 1-3 region fragments of plasminogen and methods of use |
| 01/02/2007 | US7157551 Agent that specifically binds to human MTAP protein in an embedded biological sample, especially a polyclonal antibody or a monoclonal antibody produced by hybridoma cell line ATCC Accession No. PTA-5001 |
| 01/02/2007 | US7157500 Nitrosylation of protein SH groups and amino acid residues as a therapeutic modality |
| 01/02/2007 | US7157458 Bifunctional energy-reversible acyl-compositions |
| 01/02/2007 | US7157418 Methods and compositions for treating secondary tissue damage and other inflammatory conditions and disorders |
| 01/02/2007 | US7157265 useful researching on neuroplasticity and pathology of neurodegenerative disorders |
| 01/02/2007 | US7157248 Anticonvulsants; anxiolytic agents; multiple sclerosis; isolated nucleic acids; analyzing sample; calibration |
| 01/02/2007 | US7157247 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/02/2007 | US7157243 DNA encoding mammalian T-type calcium channels |
| 01/02/2007 | US7157241 Dipeptidyl peptidase IV (DPPIV); given sequences; homology with family of prolyl oligopeptidases; drug screening for enzyme inhibitors for DPPIV which could treat reproductive, inflammatory and metabolic disorders |
| 01/02/2007 | US7157238 Identifying micrometastsized tissue/masses using double immunoglobulin labeling; immunodiagnostics and cancer detection |
| 01/02/2007 | US7157237 Antibodies for enzymes of the ω-oxidation pathway and methods relating thereto |
| 01/02/2007 | US7157233 Independent of the patient's human papilloma virus (HPV) infection status by detecting biomarker(s) selectively overexpressed in high-grade cervical disease; immunocytochemistry for biomarker proteins p14ARF, p21waf1, Topo2A (topoisomerase 2 alpha), and Cyclin E; cervical cancer detection; pap smears |
| 01/02/2007 | US7157226 probes, vectors and kits; sequences from the Core/E1 region of HCV type 3; detection of HCV infection |
| 01/02/2007 | US7157225 Nucleotide sequences of HIV-1 type (or subtype) O retrovirus antigens |
| 01/02/2007 | US7157091 Endosomal targeting signal contains an endosomal targeting portion of human invariant chain Ii or LAMP-1. |
| 01/02/2007 | US7157087 Modifying selected antibodies with biotin and streptavidin, conjugating these antibodies with an effector molecule, and delivering the conjugated effector to an intracellular target |
| 01/02/2007 | US7157086 Treatment of specific and non-specific inflammation, including asthma; useful in diagnosing and localizing sites of inflammation. |
| 01/02/2007 | US7157085 Method for treating IgE-mediated disorders |
| 01/02/2007 | CA2340795C Placental organic anion transporter and gene thereof |
| 01/02/2007 | CA2326713C Use of a papillary fibroblast-specific paratope as a skin quality marker |
| 01/02/2007 | CA2237059C Targeted adenovirus vectors |
| 01/02/2007 | CA2236900C Igg separation medium and novel protein a variant |
| 01/02/2007 | CA2217236C Monoclonal antibody for immunoassay of detergents and their degradation products and its use |
| 12/28/2006 | WO2006138737A2 Methods of purifying anti a beta antibodies |
| 12/28/2006 | WO2006138721A1 Anti-gfralpha3 antibodies |
| 12/28/2006 | WO2006138694A2 Rabbit monoclonal antibody against id1 protein |
| 12/28/2006 | WO2006138690A2 Improved method of treating degenerative spinal disorders |
| 12/28/2006 | WO2006138670A2 Antibody complexes |
| 12/28/2006 | WO2006138553A2 Methods of purifying fc region containing proteins |
| 12/28/2006 | WO2006138527A2 Genes of an otitis media isolate of nontypeable haemophilus influenzae |
| 12/28/2006 | WO2006138520A2 Methods for isolating and concentrating biological materials using continuous-flow ultracentrifugation |
| 12/28/2006 | WO2006137354A1 Antibody having inhibitory effect on amyloid fibril formation |
| 12/28/2006 | WO2006136697A2 Chimeric poly peptides and the therapeutic use thereof against a flaviviridae infection |
| 12/28/2006 | WO2006136601A1 Optimization of west nile virus antibodies |
| 12/28/2006 | WO2006136392A2 Novel genes and proteins of brachyspira pilosicoli and use of same for diagnosis and therapy |
| 12/28/2006 | WO2006119107A3 Sclerostin binding agents |
| 12/28/2006 | WO2006116246A3 Method of treating cd30 positive lymphomas |
| 12/28/2006 | WO2006114284A3 AGONISTIC ANTIBODIES THAT BIND TO THE LT-β-RECEPTOR AND THEREBY MODULATE ADIPOSITY-ASSOCIATED PHENOTYPES AS WELL AS THEIR USE IN THERAPY |
| 12/28/2006 | WO2006111372A3 Phytase |
| 12/28/2006 | WO2006110748A3 Response gene to complement 32 (rgc-32) in disease |
| 12/28/2006 | WO2006108670A3 Use of cd25 antibodies in immunotherapy |
| 12/28/2006 | WO2006103100A3 Antibodies against ccr5 and uses thereof |
| 12/28/2006 | WO2006102408A3 Methods and compositions for the modulation of immune responses and autoimmune diseases |
| 12/28/2006 | WO2006099480A3 Stress proteins and peptides and methods of use thereof |
| 12/28/2006 | WO2006096490A3 ANTI-MAdCAM ANTIBODY COMPOSITIONS |
| 12/28/2006 | WO2006089251A3 SYNERGISTIC EFFECT OF TGF-β BLOCKADE AND IMMUNOGENIC AGENTS ON TUMORS |
| 12/28/2006 | WO2006074397A3 Cripto binding molecules |
| 12/28/2006 | WO2006072625A3 Anti-kir combination treatments and methods |
| 12/28/2006 | WO2006063075A3 Hemipteran octopamine receptor |
| 12/28/2006 | WO2006036745A3 Il-23p40 specific immunoglobulin derived proteins, compositions, epitopes, methods and uses |
| 12/28/2006 | WO2006003518A3 6-phosphorylcholine-n-acetyl-d-galactosamine conjugate molecules and their use in vaccinal, therapeutic and diagnostic applications against bacterial infection of the respiratory tract |
| 12/28/2006 | WO2005098433A3 Diagnostic assays for alzheimer’s disease |
| 12/28/2006 | WO2005090406A3 Antibodies binding to ephb4 for inhibiting angiogenesis and tumor growth |
| 12/28/2006 | WO2005079423A3 Chemically programmable immunity |
| 12/28/2006 | WO2005054295A3 Therapeutic and diagnostic anti-hsp 70 antibodies |
| 12/28/2006 | US20060294614 Orphan receptors; drug screening; host cells |
| 12/28/2006 | US20060294612 Gpcr-like retinoic acid-induced gene 1 protein and nucleic acid |
| 12/28/2006 | US20060294608 Novel haemopoietin receptor and genetic sequences encoding same |
| 12/28/2006 | US20060294605 Novel human dickkopf-related protein and nucleic acid molecules and uses therefor |
| 12/28/2006 | US20060294602 Diagnostic and therapeutic use of a rab family gtp-binding protein for neurodegenerative diseases |
| 12/28/2006 | US20060294601 Compositions, organisms and methodologies employing a novel human kinase |
| 12/28/2006 | US20060293506 Antibodies directed to PDGFD and uses thereof |
| 12/28/2006 | US20060293254 Podophyllotoxin |
| 12/28/2006 | US20060293239 Treatment and Diagnosis of Insulin-Resistant States |
| 12/28/2006 | US20060292669 Mammalian prickle gene |